[MISC] QoQ Quarter Result on 30-Jun-2020 [#2]

Stock
[MISC] MISC BHD
Announcement Date
13-Aug-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
30-Jun-2020 [#2]
Profit Trend
QoQ- 125.89%
YoY- -25.09%
Quarter Report
Latest QR
Upcoming QR
MISC's Result
MISC's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 2,540,900 2,641,600 2,059,500 2,186,300 2,513,800 2,375,500 2,147,800 11.84%
PBT 405,700 554,600 281,200 186,000 -1,145,400 263,700 287,500 25.78%
Tax -10,100 1,900 -20,800 -21,700 -5,600 -16,300 -16,600 -28.17%
NP 395,600 556,500 260,400 164,300 -1,151,000 247,400 270,900 28.68%
-
NP to SH 429,800 556,000 258,300 299,500 -1,156,800 249,900 266,100 37.62%
-
Tax Rate 2.49% -0.34% 7.40% 11.67% - 6.18% 5.77% -
Total Cost 2,145,300 2,085,100 1,799,100 2,022,000 3,664,800 2,128,100 1,876,900 9.31%
-
Net Worth 33,433,860 32,273,274 32,987,481 33,924,879 34,415,898 34,728,364 35,487,209 -3.89%
Dividend
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Div 312,466 535,656 312,466 312,466 312,466 535,656 312,466 0.00%
Div Payout % 72.70% 96.34% 120.97% 104.33% 0.00% 214.35% 117.42% -
Equity
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Net Worth 33,433,860 32,273,274 32,987,481 33,924,879 34,415,898 34,728,364 35,487,209 -3.89%
NOSH 4,463,800 4,463,800 4,463,800 4,463,800 4,463,800 4,463,800 4,463,800 0.00%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 15.57% 21.07% 12.64% 7.51% -45.79% 10.41% 12.61% -
ROE 1.29% 1.72% 0.78% 0.88% -3.36% 0.72% 0.75% -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 56.92 59.18 46.14 48.98 56.32 53.22 48.12 11.83%
EPS 9.60 12.50 5.80 6.70 -25.90 5.60 6.00 36.75%
DPS 7.00 12.00 7.00 7.00 7.00 12.00 7.00 0.00%
NAPS 7.49 7.23 7.39 7.60 7.71 7.78 7.95 -3.89%
Adjusted Per Share Value based on latest NOSH - 4,463,800
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
RPS 56.92 59.18 46.14 48.98 56.32 53.22 48.12 11.83%
EPS 9.60 12.50 5.80 6.70 -25.90 5.60 6.00 36.75%
DPS 7.00 12.00 7.00 7.00 7.00 12.00 7.00 0.00%
NAPS 7.49 7.23 7.39 7.60 7.71 7.78 7.95 -3.89%
Price Multiplier on Financial Quarter End Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 -
Price 6.82 6.87 7.50 7.66 7.44 8.35 7.80 -
P/RPS 11.98 11.61 16.26 15.64 13.21 15.69 16.21 -18.24%
P/EPS 70.83 55.16 129.61 114.17 -28.71 149.15 130.84 -33.55%
EY 1.41 1.81 0.77 0.88 -3.48 0.67 0.76 50.92%
DY 1.03 1.75 0.93 0.91 0.94 1.44 0.90 9.40%
P/NAPS 0.91 0.95 1.01 1.01 0.96 1.07 0.98 -4.81%
Price Multiplier on Announcement Date
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Date 06/05/21 18/02/21 17/11/20 13/08/20 08/05/20 18/02/20 13/11/19 -
Price 6.77 6.40 7.41 7.87 7.90 8.02 8.30 -
P/RPS 11.89 10.81 16.06 16.07 14.03 15.07 17.25 -21.95%
P/EPS 70.31 51.38 128.06 117.30 -30.48 143.26 139.23 -36.55%
EY 1.42 1.95 0.78 0.85 -3.28 0.70 0.72 57.20%
DY 1.03 1.87 0.94 0.89 0.89 1.50 0.84 14.54%
P/NAPS 0.90 0.89 1.00 1.04 1.02 1.03 1.04 -9.18%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment